FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
ARICEPT
donepezil hydrochloride
LOE Approaching
Eisai
ORAL · SOLUTION
dementia of the Alzheimer's typeAlzheimer's disease
2004
NDA30/100
ARICEPT ODT
donepezil hydrochloride
LOE Approaching
Eisai
ORAL · TABLET, ORALLY DISINTEGRATING
dementia of the Alzheimer's typeAlzheimer's disease
2004
NDA30/100
ARIDOL
mannitol
LOE Approaching
INHALATION · POWDER
asthma
2010
NDA30/100
ARIDOL KIT
mannitol
LOE Approaching
INHALATION · POWDER
asthma
2010
NDA30/100
ARIMIDEX
anastrozole
LOE Approaching
AstraZeneca
ORAL · TABLET
advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapybreast cancer
2008
SMNDA30/100
ARIMIDEX
anastrozole
LOE Approaching
ANI Pharmaceuticals
ORAL · TABLET
advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapybreast cancer
1995
SMNDA30/100
ARISTOCORT
triamcinolone diacetate
LOE Approaching
Astellas
ORAL · SYRUP
1959
NDA30/100
ARISTOCORT
triamcinolone diacetate
LOE Approaching
Fosun Pharma
INJECTION · INJECTABLE
1961
NDA30/100
ARISTOCORT
triamcinolone diacetate
LOE Approaching
Fosun Pharma
INJECTION · INJECTABLE
1959
NDA30/100
ARISTOCORT
triamcinolone
LOE Approaching
Astellas
ORAL · TABLET
1957
NDA30/100
ARISTOSPAN
triamcinolone hexacetonide
LOE Approaching
INJECTION · INJECTABLE
1969
NDA30/100
ARIXTRA
fondaparinux sodium
LOE Approaching
Viatris (2)
SUBCUTANEOUS · SOLUTION
deep vein thrombosis (DVT) in adultswhich may lead to pulmonary embolism (PE): • in patients undergoing hip fracture surgery+8
2001
NDA30/100
AROMASIN
exemestane
LOE Approaching
Pfizer
ORAL · TABLET
advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy ()breast cancer
1999
NDA30/100
ARRANON
nelarabine
LOE Approaching
Novartis
INTRAVENOUS · INJECTABLE
T-cell lymphoblastic lymphoma (T-LBL) in adultolder whose disease has not responded to+2
2005
NDA30/100
ARTANE
trihexyphenidyl hydrochloride
LOE Approaching
Pfizer
ORAL · ELIXIR
1949
NDA30/100
ARTANE
trihexyphenidyl hydrochloride
LOE Approaching
Pfizer
ORAL · CAPSULE, EXTENDED RELEASE
1962
NDA30/100
ARTHROTEC
diclofenac sodium and misoprostol
LOE Approaching
Pfizer
ORAL · TABLET, DELAYED RELEASE
the signssymptoms of osteoarthritis+6
1997
NDA30/100
ASACOL
mesalamine
LOE Approaching
ORAL · TABLET, DELAYED RELEASE
mildly to moderately active ulcerative colitisfor the maintenance of remission of ulcerative colitis+1
1992
NDA30/100
ASACOL HD
mesalamine
LOE Approaching
AbbVie
ORAL · TABLET, DELAYED RELEASE
ulcerative colitis
2008
NDA30/100
ASCLERA
polidocanol
LOE Approaching
INTRAVENOUS · SOLUTION
2010
NDA30/100
ASENDIN
amoxapine
LOE Approaching
Pfizer
ORAL · TABLET
depressionanxiety
1980
NDA30/100
ASMANEX TWISTHALER
mometasone furoate
LOE Approaching
Merck & Co.
INHALATION · POWDER
children less than 4 years of ageasthma
2005
NDA30/100
ASTELIN
azelastine hydrochloride
LOE Approaching
NASAL · SPRAY, METERED
the symptoms of seasonal allergic rhinitis suchsneezing+8
1996
NDA30/100
ASTEPRO
azelastine hydrochrloride
LOE Approaching
Viatris (2)
NASAL · SPRAY, METERED
2009
NDA30/100